Publication | Closed Access
Multiple-Dose Pharmacodynamics and Pharmacokinetics of Anacetrapib, a Potent Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Subjects
99
Citations
16
References
2008
Year
High-density LipoproteinHealthy SubjectsBiochemistryPharmacological StudyMedicine.1,2 Clinical PharmacologyNatural SciencesOxysterolCholesteryl EstersLipid SciencePharmacotherapyMultiple-dose PharmacodynamicsLipoprotein MetabolismCellular BiochemistryPharmacologyPharmacokineticsLipid DisorderLipid Synthesis
Cholesteryl ester transfer protein (CETP) is a plasma protein that catalyzes the heteroexchange of cholesteryl esters from high-density lipoprotein (HDL) and triglycerides to apolipoprotein B–containing lipoproteins, especially very low–density lipoproteins (LDL-C).1,2 Clinical Pharmacology & Therapeutics (2008); 84, 6, 679–683 doi:10.1038/clpt.2008.109
| Year | Citations | |
|---|---|---|
2007 | 3.1K | |
2007 | 962 | |
1993 | 944 | |
2007 | 660 | |
2002 | 451 | |
2002 | 437 | |
2004 | 371 | |
2007 | 276 | |
2007 | 196 | |
2006 | 144 |
Page 1
Page 1